|
|
DSpace at RU >
Browsing by Author Rennings, A.J.M.
Showing results 1 to 8 of 8
| Full Text | Issue Date | Title | Author(s) | | 2011 | Preserved response to diuretics in rosiglitazone-treated subjects with insulin resistance: a randomized double-blind placebo-controlled crossover study | Rennings, A.J.M.; Russel, F.G.M.; Li, Y.; Deen, P.M.T.; Masereeuw, R., et al |
| 2010 | Rosiglitazone reduces ischaemia-reperfusion injury in patients with the metabolic syndrome. | Rennings, A.J.M.; Meijer, P.; Uden, D.J. van; Tack, C.J.J.; Smits, P., et al |
| 2010 | Duration of clopidogrel therapy with drug-eluting stents. | Rennings, A.J.M.; Schouwenberg, B.J.J.W.; Onzenoort, H.A.W. van |
| 2010 | Autonomic neuropathy predisposes to rosiglitazone-induced vascular leakage in insulin-treated patients with type 2 diabetes: a randomised, controlled trial on thiazolidinedione-induced vascular leakage. | Rennings, A.J.M.; Smits, P.; Stewart, M.W.; Tack, C.J.J. |
| 2009 | Vascular endothelial growth factor in systemic capillary leak syndrome. | Lesterhuis, W.J.; Rennings, A.J.M.; Leenders, W.P.J.; Nooteboom, A.; Punt, C.J.A., et al |
| 2008 | JTT-705: is there still future for a CETP inhibitor after torcetrapib? | Rennings, A.J.M.; Stalenhoef, A.F.H. |
| 2006 | Fluid retention and vascular effects of rosiglitazone in obese, insulin-resistant, nondiabetic subjects. | Rennings, A.J.M.; Smits, P.; Stewart, M.W.; Tack, C.J.J. |
| 2005 | Diazoxide-mediated insulin suppression in obese men: a dose-response study. | Schreuder, T.; Karreman, M.; Rennings, A.J.M.; Ruinemans-Koerts, J.; Jansen, M., et al |
Showing results 1 to 8 of 8
|